Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Synthesis of Remdesivir (GS-5734) — A Candidate for the Treatment of Ebola and COVID-19 Infections ; volume:16 ; number:07 ; year:2020 ; pages:0765
Synfacts ; 16, Heft 07 (2020), 0765
- DOI
-
10.1055/s-0040-1707019
- URN
-
urn:nbn:de:101:1-2020082008325148948797
- Rights
-
Open Access unbekannt; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Other Objects (12)
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19
EBOLA
EBOLA
Structural insights into plasticity and discovery of remdesivir metabolite GS-441524 binding in SARS-CoV-2 macrodomain
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
Post-Ebola sequelae among Ebola child survivors in Sierra Leone
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19
EBOLA
EBOLA
Structural insights into plasticity and discovery of remdesivir metabolite GS-441524 binding in SARS-CoV-2 macrodomain
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
Post-Ebola sequelae among Ebola child survivors in Sierra Leone
Remdesivir (COVID-19) : Nutzenbewertung gemäß § 35a SGB V
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19
EBOLA
EBOLA
Structural insights into plasticity and discovery of remdesivir metabolite GS-441524 binding in SARS-CoV-2 macrodomain
Remdesivir: A Review in COVID-19
Coronavirus-Replikation: Mechanismus und Inhibition durch Remdesivir
Untersuchung der Nephrotoxizität von Remdesivir \(in\) \(vitro\)
The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
Post-Ebola sequelae among Ebola child survivors in Sierra Leone